Sedana Medical
Carbon in Edenvale

AnaConDa is a disposable administration system for isoflurane and sevoflurane. It can be used for sedation in the ICU and for anaesthesia. It opens up the possibility to use volatile agents in an easy and safe way without the need for an anaesthesia machine.

The AnaConDa (Anaesthetic Conserving Device) is an anaesthetic delivery system, developed for the administration of Isoflurane or Sevoflurane to mechanically ventilated patients. Our customer representatives are ready to help you. The security of your Personal Information is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Information, we cannot guarantee its absolute security due to the nature of the process. Objective The Anaesthetic Conserving Device is a modified heat and moisture exchanger that enables the application of inhalation sedation with existing ventilators in intensive care units. The following review describes the advantages of inhalation sedation using the Anaesthetic Conserving Device in comparison to standard intravenous sedation for patients in intensive care units and highlights the technical aspects of its functioning. Findings Use of inhalation sedation with the Anaesthetic Conserving Device enables faster transition to spontaneous breathing and a shorter awakening time than with intravenous sedation. Even short-term inhalation sedation of patients after open heart procedures has a cardioprotective effect and reduces troponin T values. Despite increased concentrations of inorganic fluoride in serum after sevoflurane exposure, no clinical studies to date have shown its nephrotoxic effect, even after long-term (48 h) sedation. The Anaesthetic Conserving Device is accurate in maintaining target values of volatile anaesthetics. Objective Results to date show that inhalation sedation with the Anaesthetic Conserving Device may be an effective and safe alternative to existing protocols of intravenous sedation for patients requiring intensive treatment. Abstract Volatiles have expanded beyond the operating room secondary to technological advances attracting the attention of clinicians and researchers trying to improve sedation therapy and outcomes. Their unique pharmacological properties may account for shorter patient awakening and extubation times in comparison to the current standard of care. However, like all sedatives, these agents can induce deep levels of sedation that have respiratory depressant effects and reduce patient mobility. At this time, it would be prudent to conduct further research to ensure patient safety with a focus on mortality, duration of mechanical ventilation, clinically relevant end-organ protection, and early and long-term cognitive dysfunction before widespread adoption of this exciting technique. Conclusion Volatile anesthetic agent use in the intensive care unit, aided by technological advances, has become more accessible to critical care physicians. With increasing concern over adverse patient consequences associated with our current sedation practice, there is growing interest to find non-benzodiazepine-based alternative sedatives. However, like all sedatives, volatile agents are capable of deeply sedating patients, which can have respiratory depressant effects and reduce patient mobility. This review seeks to critically appraise current volatile use in critical care medicine including current research, technical consideration of their use, contraindications, areas of controversy, and proposed future research topics. Sevoflorane as adjuvant for sedation during mechanical ventilation in intensive care unit medical patients: Preliminary results of a series of cases. Objective To disclose our preliminary experience in inhalation sedation with sevoflorane in a standardized manner using the Anesthetic Conserving Device in intubated, critically ill patients in our ICU. Conclusion In our limited experience, adjuvant inhalation sedation with sevoflurane in the ICU is safe and complementary to the use of intravenous drugs such as propofol, remifentanil and midazolam, which are currently commonly used to achieve goal-directed sedation.